May 17, 2012

Study Shows Brain Mechanism May Help Some Deal With Stress Better Than Others

Some cope with stress much better than others, and a new study of mice shows that a naturally occurring mechanism in the brain promotes resilience to psychological stress.

Why is this important? In humans, stress is often associated with the development of some mental health issues such as post-traumatic stress disorder (PTSD) and depression. Results of the study, published online in the journal Cell, show that resistance to stress is not just a passive absence of stress vulnerability mechanisms as had been previously thought, but a biologically active process that results in specific adaptations in the brain’s response to stress.

The results are encouraging because a greater understanding of the brain’s function in regards to stress may help scientists discover how to enhance a naturally occurring mechanism in the brain that promotes resilience to psychological stress.

"We now know that the mammalian brain can launch molecular machinery that promotes resilience to stress, and we know what several major components are. This is an excellent indicator that there are similar mechanisms in the human brain," says Thomas R. Insel, MD, Director of the National Institute of Mental Health (NIMH).

In the study, smaller mice were put in cages with larger and more aggressive mice. Their vulnerability to stress was measured through such behaviors as social withdrawal after these encounters. While most mice adapted and continued social interactions after the stress event, some mice were overwhelmed by the interaction to the point that even after 30 days they were still avoiding social interaction with other mice.

The mice that were more traumatized by the stress showed more impulse firing by the cells that make dopamine, while the mice that were able to adapt maintained normal rates of impulse-firing due to a a protective mechanism—increased activity of channels that allow potassium to flow to the cells, which dampens the firing rate.

The higher firing rates in the traumatized mice led to more activity of a protein called BDNF, which had been linked to vulnerability in previous studies by the same researchers. With their comparatively lower rates of impulse-firing, the resistant mice did not have this increase in BDNF activity, another factor that contributed to resistance.

The scientists found that these mechanisms occurred in the reward area of the brain, which promotes repetition of acts that ensure survival. The areas involved were the VTA (ventral tegmental area) and the NAc (nucleus accumbens). In genetic experiments on the stress-resistant mice, many more genes in the VTA than in the NAc went into action in stressful situations, compared with vulnerable mice. Gene activity governs numerous biochemical events in the brain, and the results of this experiment suggest that genes in the VTA of resilient mice are working hard to offset mechanisms that promote vulnerability.

Another component of the study revealed that mice with a naturally occurring variation in part of the gene that produces the BDNF protein are resistant to stress. The variation results in lower production of BDNF, consistent with the finding that low BDNF activity promotes resilience.

The scientists also examined brain tissue of deceased people with a history of depression, and compared it with brain tissue of mice that showed vulnerability to stress. In both cases, the researchers found higher-than-average BDNF protein in the brain’s reward areas, offering a potential biological explanation of the link between stress and depression.

"The fact that we could increase these animals’ ability to adapt to stress by blocking BDNF and its signals means that it may be possible to develop compounds that improve resilience. This is a great opportunity to explore potential ways of increasing stress-resistance in people faced with situations that might otherwise result in post-traumatic stress disorder, for example," said Eric J. Nestler, MD, PhD, one of the study’s authors.

"But it doesn’t happen in a vacuum. Blocking BDNF at certain stages in the process could perturb other systems in negative ways. The key is to identify safe ways of enhancing this protective resilience machinery," Nestler added.

The study was published by Vaishnav Krishnan, Ming-Hu Han, PhD, Eric J. Nestler, MD, PhD, and colleagues from the University of Texas Southwestern Medical Center, Harvard University, and Cornell University, and was funded by the National Institute of Mental Health (NIMH).

Sources:

  • National Institutes of Health
  • Cell, October 18, 2007

Vision and Hearing Impairment May Contribute to Depression in Seniors

It is commonly known that hearing and vision impairment are much more pronounced in the elderly population. With the gradual onset of hearing and vision loss, certain tasks become more difficult for seniors.

In addition to the direct difficulties, such as having trouble reading smaller type or understanding conversations, hearing and vision loss is also associated with the development of mood disorders, according to Dennis Norman, Chief of Psychology at Massachusetts General Hospital.

"Vision and hearing loss are major public health issues because they affect so many older individuals, and because they have an adverse impact on mental health," says Norman. "If the senses are limited, everything is affected, including interaction with surroundings, relationships, activities, and feelings of self-worth. Impairment can lead to depression, anxiety, social isolation and many other problems."

According to the Centers for Disease Control, approximately 3.6 million Americans over the age of 70 have impaired vision, and 6.7 million older adults report impaired hearing.

The CDC also indicates that these individuals also are more likely to experience problems in other activities of daily life, such as walking, going outdoors, getting in and out of chairs or bed, or managing their prescription medications. They are also less likely to socialize than individuals without sensory impairment.

A recent study reported in Archives of Ophthalmology (April 2006) also suggests that there’s a significant link between visual problems and thinking, memory and learning.

Hearing impairment has also been linked to cognitive decline. Brandeis University researchers suggest that mental resources are expended toward efforts to hear, at the expense of memory.

Preventive Measures to Protect from Hearing and Vision Impairment

  • Wear sunglasses to reduce exposure to UV radiation
  • Protect ears by avoiding loud noises, wearing earplugs, and keep earphone volume down
  • Stay healthy with regular medical checkups, quitting smoking, and managing conditions such as diabetes and high blood pressure that can damage eyes and/or ears.
  • Maintain a healthful diet: Get plenty of vitamin C through citrus fruits and juices; eat carrots and dark-green leafy vegetables such as spinach for beta-carotene; eat whole grains, nuts, and eggs for vitamin E; and get needed zinc from fish, meats, whole grains and dairy products. For nutrients that strengthen or protect hearing, eat foods rich in: vitamin D (fortified dairy products, seafood, fortified cereals); vitamin B12 (meat, poultry, eggs, dairy products and shellfish); and folate (liver, eggs, beans, fortified cereals, leafy green vegetables, and fruits).
  • Consider supplements. Ask your doctor about taking supplements such as bilberry (huckleberry), ginkgo biloba and vinpocetine.

Helpful Resources
These groups offer support and information to help people cope with hearing and vision impairment:

Source: Newswise

Donepezil Shows Promise for Severe Alzheimer’s

In a study released last week published in the Journal of the American Academy of Neurology, the drug donepezil has improved the cognitive functioning and memory of individuals with severe Alzheimer’s disease.

 
The study, funded by Eisai Inc. and Pfizer, makers of the drug, took place over six months and studied 343 individuals.Half of the group took donepezil and the other half received a placebo.

The results showed that over 63% of the individuals demonstrated memory stabilization or increased function, compared to 39% on the placebo.

Angry Men at Higher Risk for Heart Disease, Diabetes

It’s not healthy to be hostile, according to a recent study from Duke University.

Steven Boyle, Ph.D., a researcher at Duke University Medical Center, says men who regularly exhibit strong feelings of anger or depression may face increased risk of coronary heart disease.

The study was conducted on 313 men who were given a standard psychological test that measures hostility, anger and depression.

Men whose psychological screening showed the highest level of hostility, depressive symptoms and anger had a 7.1 percent increase in levels of an immunity protein known as C3, while men with lower levels of hostility, depression and anger showed no during the decade-long study.

According to the study’s co-author, Edward Suarez, Ph.D., the lifestyle of individuals with a hostile attitude, "often leads to greater stress and possibly changes in the way the body functions that could lead to disease.”

The study appears in the August issue of the journal Brain, Behavior, and Immunity.

Source: Health Behavior News Service

Study Claiming Cannabis – Schizophrenia Link Fuels Debate

A controversy has been sparked by a Swiss study, which claims that a link has been established between smoking canabis and developing schizophrenia.

The study concludes that there was an increase in occurrences of schizophrenia during the 90s, which is considered to be a liberal period, and corresponds to higher canabis usage. The critics, however, have pointed out that the study is inconclusive as it is does not take into consideration the individual patients’ drug usage.

Researchers claim that there is a direct relationship between the development of the disease and the rate of canabis consumption. They add that regular smokers of cannabis are at increased risk of developing schizophrenia by two to three times.

Experts on drug issues have welcomed the report, but they also remain cautious. They believe that the hypothesis may indeed be true, but that the results are not conclusive.

Lithium Evaluated for Treating Bipolar Disorder in Children

University of Illinois at Chicago is performing a national study to assess the benefits of lithium in treating children and adolescents with bipolar disorders.

Lithium is already proven to be effective in the treatment of adults suffering from bipolar disorders. This study will help in determining if Lithium has the same beneficial effect on pediatric patients.

The study involves evaluating efficiency of the drug, its dosage strategies, and the short-term and long-term tolerance and safety of the drug.
Bipolar disorder in children is usually referred as the pediatric bipolar disorder or manic depressive disorder. It is diagnosed when severe mood swings are noticed in a child.

The disorder hampers the normal behavior of the child and may give rise to suicidal tendencies. A child suffering from this disorder may exhibit poor school attendance and might show risk-taking behavior, such as substance abuse and involvement in risky sexual activities.

Source: University of Illinois at Chicago